| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Biotechnology
| Recent advancements in the development of personalized mRNA-based cancer vaccines, particularly for melanoma, indicate a significant breakthrough in cancer treatment. Multiple articles reflect strong positive sentiment regarding Moderna's progress, suggesting a robust pipeline that extends beyond COVID-19 vaccine solutions. This optimism is bolstered by successful trials, generating enthusiasm among analysts and investors. The focus on cancer vaccine breakthroughs positions Moderna as a leader in innovative therapeutic solutions. |
| The price action of Moderna Inc (MRNA) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 9.5 is extremely bullish. The market sentiment at 3.2 is extremely bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. MRNA is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 3.7, and the negative at -0.5 on 2026-08-21. The forces of Stock Price Trend (9.5), Market Risk Appetite (5.7), Sentiment towards Fundamentals (4.6), Sector Price Trend (2.2), and Option Sentiment (1.5) will drive up the price. The forces of Price Level Sentiment (-1), and Valuation Sentiment (-2) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| MRNA | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-21 | 0%(0.4%) | 144.98 | 23.28% | 104 | 75 | 0 | 8.75% | 10.68% | 9.5 | 0 | 1% | 2.5 | Long | 70% | 4.6 | 3 |
| 2026-08-20 | 1%(0.4%) | 133.32 | 22.16% | 105 | 73 | 0 | -23.55% | 10.88% | 9.5 | 0 | 1% | 2.5 | Long | 70% | 5.7 | 3.6 |
| 2026-08-19 | 2%(0.3%) | 174.38 | 14.63% | 158 | 94 | 0 | 176.97% | 19.41% | 9.5 | 0 | 1% | 2.5 | Wait | 50% | 6.4 | 6.8 |
| 2026-08-18 | 0%(0%) | 62.96 | 5.56% | 83 | 67 | 0 | -2.33% | 1% | 1.7 | 0 | 1% | 1.1 | Long | 65% | 4.4 | -1 |
| 2026-08-17 | 0%(0%) | 64.46 | 5.21% | 97 | 68 | 0 | 1.8% | 1.69% | 2.8 | 0 | 1% | 1.3 | Long | 70% | 4.4 | -1 |
| 2026-08-16 | 0%(0%) | 2.3 | 0 | 2.3 | 4.4 | -1 | ||||||||||
| 2026-08-15 | 0%(0%) | 2.3 | 0 | 2.3 | 3.9 | -1 | ||||||||||
| 2026-08-14 | 0%(0%) | 63.32 | 4.83% | 93 | 66 | 0 | -0.52% | 1.37% | 2.3 | 0 | 1% | 2.4 | Long | 55% | 3.9 | -1 |
| 2026-08-13 | 0%(0%) | 63.65 | 4.62% | 99 | 69 | 0 | -0.03% | 1.04% | 2.7 | 0 | 1% | 2.5 | Long | 70% | 4 | -1 |
| 2026-08-12 | 0%(0%) | 63.67 | 4.55% | 100 | 62 | 0 | 5.12% | 1.58% | 2.6 | 0 | 1% | 2.3 | Long | 70% | 4.4 | -1 |
| Long is the preferred trading strategy with 70% chance of being right. Both trend sentiment and hourly trend are very strong. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| 2026-08-21 23:03:00 The stocks mentioned (MRNA, WMT, MSTR, AVGO, SPCX) have garnered significant attention, indicating their status as interesting investment opportunities. |
| 2026-08-21 23:03:00 The enthusiasm of retail investors for certain stocks during the specified week demonstrates a strong market interest and potential bullish trends. |
| 2026-08-21 17:47:28 Bessent's bond rescue strategy suggests new investment approaches in the current financial climate. |
| 2026-08-21 17:47:28 The week is characterized as volatile, suggesting a competitive and uncertain market environment. |
| 2026-08-21 17:47:28 Bitcoin's performance is discussed as its best week since February 2023, indicating positive trends in the cryptocurrency market. |
| 2026-08-21 17:47:28 The article highlights significant movements in stock prices, particularly Moderna's substantial one-day rally and Walmart's noticeable decline. |
| 2026-08-21 17:21:05 Increased interest from institutional investors and valuations based on future growth prospects reveal heightened expectations for Moderna's market position amid ongoing developments. |
| 2026-08-21 17:21:05 Moderna's strategic shift from being primarily a COVID-19 vaccine provider to a diversified biotechnology firm is emphasized through its expanding pipeline in oncology and other disease areas. |
| 2026-08-21 17:21:05 FDA updates and approvals for new vaccines, including an mRNA flu vaccine, highlight regulatory support for Moderna's innovative pipeline, boosting investor confidence. |
| 2026-08-21 17:21:05 Despite impressive gains from breakthroughs, Moderna's stock has experienced significant fluctuations, including sharp declines after record highs, raising concerns about valuation and market stability. |
| 2026-08-21 17:21:05 Moderna's advancements in personalized mRNA cancer vaccines have generated significant enthusiasm among analysts and investors, pointing to potential long-term value in its pipeline beyond COVID-19 vaccines. |